Challenges with advanced therapy medicinal products and how to meet them

  • Christian K Schneider
  • , Paula Salmikangas
  • , Bernd Jilma
  • , Bruno Flamion
  • , Lyubina Racheva Todorova
  • , Anna Paphitou
  • , Ivana Haunerova
  • , Toivo Maimets
  • , Jean-Hugues Trouvin
  • , Egbert Flory
  • , Asterios Tsiftsoglou
  • , Balázs Sarkadi
  • , Kolbeinn Gudmundsson
  • , Maura O'Donovan
  • , Giovanni Migliaccio
  • , Jānis Ancāns
  • , Romaldas Maciulaitis
  • , Jean-Louis Robert
  • , Anthony Samuel
  • , Johannes H Ovelgönne
  • Marit Hystad, Andrzej Mariusz Fal, Beatriz Silva Lima, Anca Stela Moraru, Peter Turcáni, Robert Zorec, Sol Ruiz, Lennart Akerblom, Gopalan Narayanan, Alastair Kent, Fabrizia Bignami, J George Dickson, Dietger Niederwieser, María-Angeles Figuerola-Santos, Ilona G Reischl, Claire Beuneu, Rosen Georgiev, Maria Vassiliou, Alena Pychova, Mette Clausen, Taina Methuen, Sophie Lucas, Martina Schüssler-Lenz, Vasilios Kokkas, Zsuzsanna Buzás, Niall MacAleenan, Maria Cristina Galli, Aija Linē, Jolanta Gulbinovic, Guy Berchem, Committee for Advanced Therapies (CAT)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)195-201
Number of pages7
JournalNature Reviews. Drug Discovery
Volume9
Issue number3
DOIs
Publication statusPublished - 2010

Keywords

  • European Union
  • Gene Therapy
  • Government Regulation
  • Humans
  • Stem Cell Transplantation
  • Tissue Engineering

Cite this